Lymphangioleimyomatosis: the Hong Kong experience

published_or_final_versio

Mallampati score is a good and independent predictive factor for obstructive sleep apnoea (OSA)

published_or_final_versio

THE VARIABILITY OF VERTICAL GROUND 'REACTION FORCE DATA IN COUNTERMOVEMENT JUMP

Jumping landing force is a common interest of sport scientists because it could directly reflect the impact on the lower extremities. The aim of this study is to test the variability of jumping landing GRF parameters (Peak landing force and rate to the peak) in real-like jumping situation

Gastro-oesophageal reflux in bronchiectasis

published_or_final_versio

Review of the effectiveness of a 4-week intensive pulmonary rehabilitation program in COAD patients

published_or_final_versio

Chemotherapy for advanced non-small-cell lung cancer: Role of paclitaxel and gemcitabine

Objective. To review the role of chemotherapy in advanced non-small-cell lung cancer, focusing on cisplatin-based regimens and two new drugs: paclitaxel and gemcitabine. Data sources. Medline search of the relevant English literature. Study selection. Open and randomised comparative (phases II and III) studies, and meta-analyses of cytotoxic drugs/regimens used to treat advanced non-small-cell lung cancer. Data extraction. The following factors were studied and compared: symptomatic response rates; tumour response rates; median survival time and 1-year survival rates; and side effects of cisplatin-, paclitaxel-, and gemcitabine-based regimens. Data synthesis. Using cisplatin-based chemotherapy achieves significant relief of disease-related symptoms of advanced non-small-cell lung cancer and a slight improvement in the median survival time (by approximately 1.5 months). New cytotoxic drugs that are effective and have good safety profiles include paclitaxel and gemcitabine. When used as single agents, these two drugs give response rates of approximately 25%. When used with cisplatin/carboplatin, response rates increase to 45% to 62% and 1-year survival rates increase to 40% to 60%. Conclusion. Paclitaxel, gemcitabine, and other drugs such as decetaxel and vinorelbine are promising new chemotherapeutic agents in the treatment of advanced non-small-cell lung cancer. These drugs can palliate disease symptoms and improve the median survival time. The optimal dose and treatment schedules, however, are yet to be defined.published_or_final_versio

Update on management of rhinitis

Rhinitis is common in Hong Kong. The aim of treatment is to control the symptoms and to allow an undisturbed lifestyle without the side-effects of therapy. A secondary goal is to prevent the complication of sinusitis and its sequelae. Most of these goals can be achieved by the combination of anti- allergy management, oral or topical medication and the occasional surgical intervention.published_or_final_versio

Collaboration interface in Smart Metering Scheme

Theme: Towards a safe, reliable, sustainable intelligent power systemPaper no. I9FP0475Smart meter provides intelligence to serve demand side management. The development of electrical-load-signature technology provides an effective base to enable condition-based monitoring and energy-collaboration management among stakeholders. In a smart metering scheme, the three direct contributors are supplier, estate manager and consumer. Affiliated members are appliance manufacturers and sustainability managers. It is perceived that when a platform can be developed to permit members sharing information, trading benefits, and recommending energy plans. The development of a collaboration interface is to assist the principal members in supporting each other as neighboring aide in these activities. This paper discusses on philosophies and models that shall develop the concepts; and shares the development of this interface.postprintThe 15th International Conference on Electrical Engineering (ICEE 2009), Shenyang, China, 5-9 July 2009

Langerhans' cell histiocytosis: Possible association with malignant germ cell tumour

A rare case of adult onset Langerhans' cell histiocytosis associated with dysgerminoma in a 35 year old Chinese woman is reported. The patient had a history of dysgerminoma of left ovary 15 years previously and had undergone surgery followed by radiotherapy and an uneventful recovery. She presented again in March 1994, this time with a left clavicular mass, which was shown histologically to be Langerhans' cell histiocytosis. The report illustrates the probable association between the two lesions, with some discussion on the underlying pathogenesis.published_or_final_versio

Gastro-oesophageal reflux in bronchiectasis

published_or_final_versio